Ligand validation:3F66

GBL: GAMMA-BUTYROLACTONE

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
3F66_GBL_B_1350	99%	12%	0.054	0.984	1.31	2.76	1	4	1	0	100%	1
3F66_GBL_A_3	95%	68%	0.087	0.989	0.7	0.55	-	-	0	0	100%	1
3F66_GBL_A_4	84%	62%	0.114	0.978	0.48	0.95	-	1	0	0	100%	1
3F66_GBL_A_5	80%	24%	0.102	0.952	1.33	1.76	1	2	0	0	100%	1
3F66_GBL_B_1	78%	26%	0.13	0.974	0.79	2.14	-	3	1	0	100%	1
2WD1_GBL_A_2348	58%	55%	0.136	0.914	0.56	1.17	-	1	0	0	100%	1
4KNB_GBL_A_1403	49%	64%	0.192	0.94	0.58	0.8	-	-	0	0	100%	1
4EHQ_GBL_A_205	90%	42%	0.07	0.951	1.15	1.11	1	-	0	0	100%	1
7D9X_GBL_C_401	66%	26%	0.118	0.921	2.05	0.96	3	1	1	0	100%	1
2VWD_GBL_B_1605	58%	50%	0.13	0.908	0.66	1.25	-	-	1	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.